Exploration of a potent PI3 kinase/mTOR inhibitor as a novel anti-fibrotic agent in IPF-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Exploration of a potent PI3 kinase/mTOR inhibitor as a novel anti-fibrotic agent in IPF

Published:2016-04-21 Issue:8 Volume:71 Page:701-711
ISSN:0040-6376
Container-title:Thorax
language:en
Short-container-title:Thorax

Author:

Mercer Paul F,Woodcock Hannah V,Eley Jessica D,Platé Manuela,Sulikowski Michal G,Durrenberger Pascal F,Franklin Linda,Nanthakumar Carmel B,Man Yim,Genovese Federica,McAnulty Robin J,Yang Shuying,Maher Toby M,Nicholson Andrew G,Blanchard Andy D,Marshall Richard P,Lukey Pauline T,Chambers Rachel C

Funder

GlaxoSmithKline

Medical Research Council

Biotechnology and Biological Sciences Research Council

Publisher

BMJ

Subject

Pulmonary and Respiratory Medicine

Reference39 articles.

1. The burden of idiopathic pulmonary fibrosis: an unmet public health need;Lee;Respir Med,2014

2. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis;Richeldi;N Engl J Med,2014

3. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis;King;N Engl J Med,2014

4. Novel therapeutic approaches for pulmonary fibrosis;Datta;Br J Pharmacol,2011

5. Targeting the TGFβ signalling pathway in disease;Akhurst;Nat Rev Drug Discov,2012

Cited by 162 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting the PI3K/mTOR pathway in idiopathic pulmonary fibrosis: Advances and therapeutic potential;Bioorganic & Medicinal Chemistry;2024-09

2. The Fibrotic Phenotype of Human Precision-Cut Lung Slices Is Maintained after Cryopreservation;Toxics;2024-08-30

3. Assessment of Imatinib Anti-Remodeling Activity on a Human Precision Cut Lung Slices Model;International Journal of Molecular Sciences;2024-07-26

4. Precision cut lung slices: an integrated ex vivo model for studying lung physiology, pharmacology, disease pathogenesis and drug discovery;Respiratory Research;2024-06-01

5. Delivery technologies for therapeutic targeting of fibronectin in autoimmunity and fibrosis applications;Advanced Drug Delivery Reviews;2024-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3